Gemini Bio

Gemini Bio, established in 1985, serves the global biotechnology industry from basic research to commercial production. It is committed to accelerating the development of life-enhancing biotherapies by simplifying and improving customers' workflows in cell culture and processing liquid manufacturing. The company's products are divided into two core verticals – Cell Culture Solutions and Process Liquids Solutions. Gemini Bio is an ISO 13485 certified and FDA-registered Class I medical device manufacturer. It produces bioproducts and chemical reagents for the global cell culture community. It offers cell culture sera such as fetal bovine, specialty fetal bovine, other non-fetal, human, and animal sera; custom and specialized media, supplements, and reagents including amino acids, antibiotics and antifungals, culture supplements and proteins, recombinant proteins, attachment factors, and cell dissociation reagents.